Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Dimitra Grapsa, Konstantinos Syrigos & Muhammad Wasif Saif. (2016) Nanoliposomal irinotecan for treating pancreatic cancer. Expert Opinion on Orphan Drugs 4:5, pages 541-547.
Read now
Read now
Yanxun Li, Jinjin Sun, Zhijia Jiang, Linqiang Zhang & Geng Liu. (2015) Gemcitabine and S-1 combination chemotherapy versus gemcitabine alone for locally advanced and metastatic pancreatic cancer: a meta-analysis of randomized controlled trials in Asia. Journal of Chemotherapy 27:4, pages 227-234.
Read now
Read now
Articles from other publishers (10)
Suravi Pramanik, Yingling Chen, Heyu Song, Irine Khutsishvili, Luis A Marky, Sutapa Ray, Amarnath Natarajan, Pankaj K Singh & Kishor K Bhakat. (2022)
The human AP-endonuclease 1 (APE1) is a DNA G-quadruplex structure binding protein and regulates
KRAS
expression in pancreatic ductal adenocarcinoma cells
. Nucleic Acids Research 50:6, pages 3394-3412.
Crossref
Crossref
Shailendra K. Gautam, Vipin Dalal, Maneesh Jain & Surinder K. Batra. 2022. Systemic Drug Delivery Strategies. Systemic Drug Delivery Strategies
437
461
.
Qiang Yan, Chenming Ni, Yingying Lin, Xu Sun, Zhenhua Shen, Minjie Zhang, Shuwen Han, Jiemin Shi, Jing Mao, Zhe Yang & Weilin Wang. (2021) ELK1 Enhances Pancreatic Cancer Progression Via LGMN and Correlates with Poor Prognosis. Frontiers in Molecular Biosciences 8.
Crossref
Crossref
K. Sudhakara Prasad, Yousef Abugalyon, Chunqiang Li, Feng Xu & XiuJun Li. (2020) A new method to amplify colorimetric signals of paper-based nanobiosensors for simple and sensitive pancreatic cancer biomarker detection. The Analyst 145:15, pages 5113-5117.
Crossref
Crossref
Wenying Yan, Xingyi Liu, Yibo Wang, Shuqing Han, Fan Wang, Xin Liu, Fei Xiao & Guang Hu. (2020) Identifying Drug Targets in Pancreatic Ductal Adenocarcinoma Through Machine Learning, Analyzing Biomolecular Networks, and Structural Modeling. Frontiers in Pharmacology 11.
Crossref
Crossref
Claudia Di Carlo, Jessica Brandi & Daniela Cecconi. (2018) Pancreatic cancer stem cells: Perspectives on potential therapeutic approaches of pancreatic ductal adenocarcinoma. World Journal of Stem Cells 10:11, pages 172-182.
Crossref
Crossref
E. A. Dubtsova, L. V. Vinokurova, K. A. Nikolskaya, M. A. Kiryukova & D. S. Bordin. (2018) Chronic pancreatitis as a risk factor for pancreatic cancer (a clinical case). Almanac of Clinical Medicine 46:5, pages 542-549.
Crossref
Crossref
Qiang Yan, Wen-Bin Yuan, Xu Sun, Ming-Jie Zhang, Feng Cen, Shi-Yu Zhou, Wan-Bo Wu, Yong‑Can Xu, Li-Hui Tong & Zhi-Hong Ma. (2018) Asparaginyl endopeptidase enhances pancreatic ductal adenocarcinoma cell invasion in an exosome-dependent manner and correlates with poor prognosis. International Journal of Oncology.
Crossref
Crossref
Chiara Birtolo, Vay Liang W. Go, Andrzej Ptasznik, Guido Eibl & Stephen J. Pandol. (2016) Phosphatidylinositol 3-Kinase. Pancreas 45:1, pages 21-31.
Crossref
Crossref
Maria Marlow, Mohammed Al-Ameedee, Thomas Smith, Simon Wheeler & Michael J. Stocks. (2015) Linifanib – a multi-targeted receptor tyrosine kinase inhibitor and a low molecular weight gelator. Chemical Communications 51:29, pages 6384-6387.
Crossref
Crossref